OUTLOOK THERAPEUTICS
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,505 | $0 | $170 | $170 |
Gross Profit | 1,065 | -29 | -28 | 85 |
EBITDA | -20,073 | -12,362 | -21,578 | 5,720 |
EBIT | -20,103 | -12,391 | -21,606 | 5,691 |
Net Income | -20,152 | -46,357 | 17,378 | 5,691 |
Net Change In Cash | 1,505 | 0 | 170 | 170 |
Free Cash Flow | -11,901 | -16,583 | -10,967 | -16,981 |
Cash | 8,900 | 7,556 | 5,702 | 14,927 |
Basic Shares | 36,957 | 30,874 | 24,234 | 18,549 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $170 | $0 | $0 | $0 |
Gross Profit | -113 | -44 | -204 | -262 |
EBITDA | -72,093 | -57,375 | -64,357 | -51,511 |
EBIT | -72,206 | -57,420 | -64,562 | -51,773 |
Net Income | -75,367 | -58,983 | -66,052 | -53,163 |
Net Change In Cash | 170 | 0 | 0 | 0 |
Cost of Revenue | 2,919 | 1,941 | ||
Free Cash Flow | -68,793 | -42,973 | -56,674 | -54,253 |
Cash | 14,927 | 23,391 | 17,396 | 14,477 |
Basic Shares | 18,549 | 12,508 | 10,604 | 7,633 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.55 |
2025-03-31 | -$0.33 |
2024-12-31 | -$0.89 |
2024-09-30 | -$0.93 |
